In brief
In a move that emphasizes loyalty over traditional qualifications, former WWE CEO Linda McMahon has been nominated as education secretary, while Dr. Mehmet Oz is set to take charge of the Centers for Medicare and Medicaid Services.
Former President Donald Trump has announced the nomination of Linda McMahon, ex-CEO of World Wrestling Entertainment (WWE), as his education secretary, and celebrity physician Dr. Mehmet Oz to head the Centers for Medicare and Medicaid Services (CMS). McMahon, a long-time Trump ally who previously led the Small Business Administration, is poised for a significant role in implementing Trump's pledge to dismantle the Department of Education. Trump, who has openly criticized the agency, stated that McMahon's advocacy for parents' rights uniquely positions her to facilitate this transition. Despite her minimal background in education, her confirmation in the Republican-controlled Senate appears likely due to her strong ties to Trump and her leadership role at the America First Policy Institute.On the other hand, Dr. Mehmet Oz, known for his controversial television health advice, will take command of the CMS, which oversees essential health programs affecting millions of Americans. Although Oz comes with a medical background as a cardiothoracic surgeon, he faces scrutiny for promoting treatments that experts label as dubious, including unapproved weight-loss drugs and unproven COVID-19 medications. Both McMahon and Oz will require Senate confirmation before officially assuming their posts.As the Trump administration prepares for this anticipated term, the focus on loyalty in cabinet appointments suggests a substantial shift in federal education and healthcare policies, echoing previous criticisms of government agencies perceived as promoting liberal ideologies. The implications of these appointments may significantly alter healthcare oversight and educational governance in America, reflecting a broader agenda aimed at transferring authority to state governments and limiting federal influence. The future of these appointments remains contingent on Senate approval in the coming year.
